Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Pharmacy Challenges in Cardiac Care During COVID-19: Lessons Learnt
Author(s): Andrew McRae Added: 1 year ago

Heart Failure

COVID-19
Foreword

Article

Author(s): Andrew JS Coats , Giuseppe Rosano Added: 3 years ago
It is with great pleasure that we introduce to you to this issue of Cardiac Failure Review. In this issue, we focus on clinical practice research and observations in advanced heart failure, a topic of increasing interest to triallists, innovators and practising physicians alike. We know the prognosis and outlook remains poor for advanced heart failure, especially if the patient is unlikely… View more

Heart Failure
Job title: MD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Dr Hajjar is the Director of the Cardiovascular Research Center and the Arthur and Janet C Ross Professor of Medicine at the Mount Sinai School of Medicine. His research focuses on molecular mechanisms of heart failure (HF) and his team has validated the cardiac sarcoplasmic reticulum calcium ATPase pump (SERCA2a) as a target in HF, developed methodologies for cardiac-directed gene therapy,… View more
Global Heart Failure Burden
Author(s): Bahira Shahim , Chris J Kapelios , Gianluigi Savarese , et al Added: 8 months ago

Heart Failure
HFSA 2020: Primary HELP Trial Results - Dr Barry A Borlaug
Author(s): Barry Borlaug Added: 3 years ago
For PH-HFpEF patients, the heart muscles are too weak to pump blood properly, despite the fact that the heart beats normally and is an area with no approved treatment options. In this video, Dr Borlaug (Mayo Clinic, Rochester, US) discusses the primary results of the Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF (HELP) trial. Questions: 1. What is the rationale behind this… View more

Heart Failure
Christian P Schulze
Job title: University Hospital Jena, Jena, Germany
CardioMEMS Implantation Using Gadolinium-based Contrast Agent: A Case Report
Author(s): Aniket S Rali , Lynne W Stevenson , Sandip K Zalawadiya Added: 3 years ago

Heart Failure
Research Area(s) / Expertise:

Coronary Physiology

Intervention

 Job title: Consultant Interventional Cardiologist
Dr Peter O'Kane has been Editor-in-Chief ofInterventional Cardiology: Reviews, Research, Resources(ICR3) since July 2021. Dr Peter O’Kane was appointed as a consultant interventional cardiologist at Royal Bournemouth Hospital in July 2007 and has performed more than 7000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the… View more
CardioNerds @AHA23: ARIES HM3: Avoidance of Aspirin with LVAD Devices
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 4 months ago
AHA 2023 - Investigator, Dr Mandeep Mehra (Brigham and Women's Hospital, US) is interviewed by Dr Christian Inchaustegui (Oregon Health & Science University, US), CardioNerds Ambassador, on the findings of the ARIES HM3 trial (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES… View more

Heart Failure

Electrophysiology & Arrhythmia
AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial
Author(s): Harriette Van Spall , Mandeep Mehra Added: 5 months ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were… View more

Heart Failure

Electrophysiology & Arrhythmia